Postliver Transplant Allograft Reinfection with a Lamivudine-Resistant Strain of Hepatitis B Virus: Long Term Follow-up
Lamivudine is a nucleoside analogue with efficacy in the suppression of hepatitis B viral (HBV) replication. In a previously reported study, lamivudine was administered to patients with chronic, actively replicating HBV infection who subsequently underwent liver transplantation. Patients became seru...
Saved in:
| Main Authors: | Eric M Yoshida, Mang M Ma, Jennifer E Davis, Karl P Fischer, Norman M Kneteman, Siegfried R Erb, D Lorne Tyrrell, Vincent G Bain |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1998-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1998/617039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Lamivudine in Decompensated Cirrhosis Secondary to Hepatitis B: Cautious Optimism in the War Not Yet Won
by: Eric M Yoshida
Published: (2001-01-01) -
Late Acute Rejection Occuring in Liver Allograft Recipients
by: Eric M Yoshida, et al.
Published: (1996-01-01) -
QUANTITATION OF LAMIVUDINE BY UV SPECTROPHOTOMETRY
by: Y. A. Gonchikova, et al.
Published: (2017-07-01) -
Acute graft versus host disease postliver transplant with mucocutaneous manifestations and pancytopenia: Remission with Janus kinase inhibitor
by: Roy Mendoza, BS, et al.
Published: (2025-08-01) -
Compatibility Study of Lamivudine with Various Cellulose Polymers
by: P. Narayana Raju, et al.
Published: (2009-01-01)